BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 8388690)

  • 21. Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
    Reiners KS; Hansen HP; Krüssmann A; Schön G; Csernok E; Gross WL; Engert A; Von Strandmann EP
    Immunology; 2004 Jun; 112(2):228-36. PubMed ID: 15147566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens.
    Savage CO; Gaskin G; Pusey CD; Pearson JD
    Exp Nephrol; 1993; 1(3):190-5. PubMed ID: 7915959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
    Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
    Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
    Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
    Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
    Csernok E; Gross WL
    Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues.
    Braun MG; Csernok E; Gross WL; Müller-Hermelink HK
    Am J Pathol; 1991 Oct; 139(4):831-8. PubMed ID: 1656761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies.
    Sommarin Y; Rasmussen N; Wieslander J
    Exp Nephrol; 1995; 3(4):249-56. PubMed ID: 8590038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis.
    Gross WL; Csernok E
    Curr Opin Rheumatol; 1995 Jan; 7(1):11-9. PubMed ID: 7718417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detachment and cytolysis of human endothelial cells by proteinase 3.
    Ballieux BE; Hiemstra PS; Klar-Mohamad N; Hagen EC; van Es LA; van der Woude FJ; Daha MR
    Eur J Immunol; 1994 Dec; 24(12):3211-5. PubMed ID: 7805749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wegener's granulomatosis.
    Lamprecht P; Gross WL
    Herz; 2004 Feb; 29(1):47-56. PubMed ID: 14968341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
    Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
    Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.
    Fujinaga M; Chernaia MM; Halenbeck R; Koths K; James MN
    J Mol Biol; 1996 Aug; 261(2):267-78. PubMed ID: 8757293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin.
    Rooney CP; Taggart C; Coakley R; McElvaney NG; O'Neill SJ
    Am J Respir Cell Mol Biol; 2001 Jun; 24(6):747-54. PubMed ID: 11415941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.
    Lesavre P; Noël LH; Gayno S; Nusbaum P; Reumaux D; Erlinger S; Grünfeld JP; Halbwachs-Mecarelli L
    J Autoimmun; 1993 Apr; 6(2):185-95. PubMed ID: 8388691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of detecting of autoantibodies against neutrophil cytoplasmic components in Wegener's granulomatosis.
    Chng HH; Ganz T; Saxon A
    Ann Allergy; 1989 Nov; 63(5):411-6. PubMed ID: 2817531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.
    Niles JL; McCluskey RT; Ahmad MF; Arnaout MA
    Blood; 1989 Nov; 74(6):1888-93. PubMed ID: 2679910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis.
    Sibilia J; Benlagha K; Vanhille P; Ronco P; Brouet JC; Mariette X
    J Immunol; 1997 Jul; 159(2):712-9. PubMed ID: 9218586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides.
    Rasmussen N; Petersen J
    J Autoimmun; 1993 Apr; 6(2):227-36. PubMed ID: 8499060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Csernok E; Szymkowiak CH; Mistry N; Daha MR; Gross WL; Kekow J
    Clin Exp Immunol; 1996 Jul; 105(1):104-11. PubMed ID: 8697616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.